ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS IN COMBINATION WITH CHK1 INHIBITORS FOR TREATING CANCER
- 专利权人:
- THRESHOLD PHARMACEUTICALS; INC.
- 发明人:
- Charles Hart,Fanying Meng,Jessica Sun
- 申请号：
- US14367168
- 公开号：
- US20150005263A1
- 申请日:
- 2012.12.20
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- Cancer can be treated by administration of TH-302 in combination with a Chk1 inhibitor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- CHK1 및 ATR 저해제의 병용물을 사용하는 암의 치료 방법
- TRAITEMENT DU CANCER
- Administration of hypoxia activated prodrug in combination with CHK1 inhibitor to treat cancer
- Treatment of Cancer with Enzalutamide and a CYP3A4 Inhibitor
- ADMINISTRATION DE PROMÉDICAMENTS ACTIVÉS PAR L'HYPOXIE EN COMBINAISON À DES INHIBITEURS DE CHK1 POUR LE TRAITEMENT DU CANCER
